TSXV - Delayed Quote CAD

Lumiera Health Inc. (NHP.V)

0.0050 0.0000 (0.00%)
At close: December 8 at 9:30 AM EST
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
11/30/2022
11/30/2021
11/30/2020
Total Revenue
433.2940
630.6450
538.1310
504.1850
Cost of Revenue
376.2160
486.2440
270.3910
216.8040
Gross Profit
57.0780
144.4010
267.7400
287.3810
Operating Expense
605.9930
1,542.0380
2,161.5990
1,405.7420
Operating Income
-548.9150
-1,397.6370
-1,893.8590
-1,118.3610
Net Non Operating Interest Income Expense
-427.6220
-804.2570
-1,594.1800
-167.3220
Other Income Expense
--
-568.4220
2,284.6470
-643.0190
Pretax Income
-1,725.2930
-2,770.3160
-1,203.3920
-1,928.7020
Net Income Common Stockholders
-1,725.2930
-2,770.3160
-1,203.3920
-1,928.7010
Diluted NI Available to Com Stockholders
-1,725.2930
-2,770.3160
-1,203.3920
-1,928.7010
Basic EPS
-0.01
-0.02
-0.01
-0.03
Diluted EPS
-0.01
-0.02
-0.01
-0.03
Basic Average Shares
169,965.2170
169,965.2170
122,167.0420
66,457.8140
Diluted Average Shares
169,965.2170
169,965.2170
122,167.0420
66,457.8140
Rent Expense Supplemental
37.7840
35.9920
36.2100
34.3860
Total Expenses
982.2090
2,028.2820
2,431.9900
1,622.5460
Net Income from Continuing & Discontinued Operation
-1,725.2930
-2,770.3160
-1,203.3920
-1,928.7010
Normalized Income
-976.5370
-2,201.8940
-3,488.0390
-1,285.6820
Interest Expense
424.2770
797.8270
1,585.1880
161.3420
Net Interest Income
-427.6220
-804.2570
-1,594.1800
-167.3220
EBIT
-1,301.0160
-1,972.4890
381.7960
-1,767.3600
EBITDA
-1,268.8620
-1,887.9210
466.2040
-1,751.2550
Reconciled Cost of Revenue
376.2160
486.2440
270.3910
216.8040
Reconciled Depreciation
32.1540
84.5680
84.4080
16.1050
Net Income from Continuing Operation Net Minority Interest
-1,725.2930
-2,770.3160
-1,203.3920
-1,928.7010
Total Unusual Items Excluding Goodwill
-748.7560
-568.4220
2,284.6470
-643.0190
Total Unusual Items
-748.7560
-568.4220
2,284.6470
-643.0190
Normalized EBITDA
-520.1060
-1,319.4990
-1,818.4430
-1,108.2360
11/30/2020 - 11/20/2013

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade